Literature DB >> 15193125

Expression of neutral glycosphingolipids in cytokine-stimulated human endothelial cells.

T Zemunik1, A Markotić, A Marusić.   

Abstract

We compared immunohistochemical distribution of glycosphingolipids globotriosylceramide (GbOse(3)Cer) and globotetraosylceramide (GbOse(4)Cer) with that of E-selectin on human umbilical vein endothelial cells (HUVEC) stimulated with tumor necrosis factor (TNF)-alpha. HUVECs activated by TNF-alpha were characterized by the highest expression of E-selectin and greatest adhesion of HL-60 cells as well compared to stimulation with interleukin-1beta or lipopolysaccharide. HUVECs activated by TNF-alpha also stained intensely with globoside antibodies, especially with the GbOse(3)Cer-directed one, staining being redistributed in a concentration-dependent manner. These results indicate the possible role of GbOse(3)Cer and GbOse(4)Cer in immune effector mechanisms of endothelium such as adhesion.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15193125     DOI: 10.1023/b:biry.0000029849.82612.1a

Source DB:  PubMed          Journal:  Biochemistry (Mosc)        ISSN: 0006-2979            Impact factor:   2.487


  3 in total

1.  p38 mitogen-activated protein kinase mediates lipopolysaccharide and tumor necrosis factor alpha induction of shiga toxin 2 sensitivity in human umbilical vein endothelial cells.

Authors:  Matthew K Stone; Glynis L Kolling; Matthew H Lindner; Tom G Obrig
Journal:  Infect Immun       Date:  2007-12-17       Impact factor: 3.441

Review 2.  Elucidation of the enigma of glycosphingolipids in the regulation of inflammation and degeneration - Great progress over the last 70 years.

Authors:  Koichi Furukawa; Yuhsuke Ohmi; Yuji Kondo; Robiul H Bhuiyan; Orie Tajima; Pu Zhang; Yuki Ohkawa; Keiko Furukawa
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2019       Impact factor: 3.493

Review 3.  The Role of Glycosphingolipids in Immune Cell Functions.

Authors:  Tao Zhang; Antonius A de Waard; Manfred Wuhrer; Robbert M Spaapen
Journal:  Front Immunol       Date:  2019-01-29       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.